A growth hormone-releasing peptide promotes mitochondrial biogenesis and a fat burning-like phenotype through scavenger receptor CD36 in white adipocytes

Endocrinology

Volumn 148, Issue 3, 2007, Pages 1009-1018

  Rodrigue Way, Amélie ^a,b   Demers, Annie ^a,b   Ong, Huy ^b   Tremblay, André ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CD36 ANTIGEN; CYTOCHROME C OXIDASE; FATTY ACID TRANSPORTER; GROWTH HORMONE RELEASING FACTOR; HEXARELIN; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SCAVENGER RECEPTOR; UNCOUPLING PROTEIN 1;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BIOGENESIS; BROWN ADIPOSE TISSUE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; EPIDIDYMIS FAT; FATTY ACID METABOLISM; GENE FUNCTION; INTRACELLULAR SPACE; LIPID METABOLISM; MICROARRAY ANALYSIS; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION; WHITE ADIPOSE TISSUE;

3T3-L1 CELLS; ADIPOCYTES, WHITE; ANIMALS; ANTIGENS, CD36; ELECTRON TRANSPORT COMPLEX IV; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGOPEPTIDES; OXIDATION-REDUCTION; RECEPTORS, SCAVENGER; THERMOGENESIS;

EID: 33847038835     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0975     Document Type: Article

References (50)

1. Eckel RH, Grundy SM, Zimmet PZ 2005 The metabolic syndrome. Lancet 365:1415-1428
2. Moller DE, Kaufman KD 2005 Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 56:45-62
3. Ibrahimi A, Abumrad NA 2002 Role of CD36 in membrane transport of long-chain fatty acids. Curr Opin Clin Nutr Metab Care 5:139-145
4. Li AC, Glass CK 2002 The macrophage foam cell as a target for therapeutic intervention. Nat Med 8:1235-1242
5. Castrillo A, Tontonoz P 2004 Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Annu Rev Cell Dev Biol 20:455-480
6. Ricote M, Valledor AF, Glass CK 2004 Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis. Arterioscler Thromb Vasc Biol 24:230-239
7. Bodart V, Febbraio M, Demers A, McNicoll N, Pohankova P, Perreault A, Sejlitz T, Escher E, Silverstein RL, Lamontagne D, Ong H 2002 CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res 90:844-849
8. Demers A, McNicoll N, Febbraio M, Servant M, Marleau S, Silverstein R, Ong H 2004 Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study. Biochem J 382:417-424
9. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Van der Ploeg LH 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977
10. Kojima M, Hosoda H, Matsuo H, Kangawa K 2001 Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 12:118-122
11. Marleau S, Harb D, Bujold K, Avallone R, Iken K, Wang Y, Demers A, Sirois M, Febbraio M, Silverstein M, Tremblay A, Ong H 2005 EP80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions. FASEB J 19:1869-1871
12. Avallone R, Demers A, Rodrigue-Way A, Bujold K, Harb D, Anghel S, Wahli W, Marleau S, Ong H, Tremblay A 2006 A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor upregulates ABC sterol transporters and cholesterol efflux in macrophages through a PPARγ-dependent pathway. Mol Endocrinol 20:3165-3178
13. St. Laurent V, Sanchez M, Charbonneau C, Tremblay A 2005 Selective hormone-dependent repression of estrogen receptor β by a p38-activated ErbB2/ErbB3 pathway. J Steroid Biochem Mol Biol 94:23-37
14. Locatelli V, Rossoni G, Schweiger F, Torsello A, De Gennaro Colonna V, Bernareggi M, Deghenghi R, Muller EE, Berti F 1999 Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology 140:4024-4031
15. Zhang W, Zhao L, Lin TR, Chai B, Fan Y, Gantz I, Mulholland MW 2004 Inhibition of adipogenesis by ghrelin. Mol Biol Cell 15:2484-2491
16. Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson IC, Wells T 2004 Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145:234-242
17. Tamori Y, Masugi J, Nishino N, Kasuga M 2002 Role of peroxisome proliferator-activated receptor-γ in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 51:2045-2055
18. Perrey S, Ishibashi S, Yahagi N, Osuga J, Tozawa R, Yagyu H, Ohashi K, Gotoda T, Harada K, Chen Z, Iizuka Y, Shionoiri F, Yamada N 2001 Thiazolidinedione- and tumor necrosis factor alpha-induced downregulation of peroxisome proliferator-activated receptor γ mRNA in differentiated 3T3-L1 adipocytes. Metabolism 50:36-40
19. Brown NF, Hill JK, Esser V, Kirkland JL, Corkey BE, Foster DW, McGarry JD 1997 Mouse white adipocytes and 3T3-L1 cells display an anomalous pattern of carnitine palmitoyltransferase (CPT) I isoform expression during differentiation. Inter-tissue and inter-species expression of CPT I and CPT II enzymes. Biochem J 327(Pt 1):225-231
20. Lin J, Wu PH, Tarr PT, Lindenberg KS, St. Pierre J, Zhang CY, Mootha VK, Jager S, Vianna CR, Reznick RM, Cui L, Manieri M, Donovan MX, Wu Z, Cooper MP, Fan MC, Rohas LM, Zavacki AM, Cinti S, Shulman GI, Lowell BB, Krainc D, Spiegelman BM 2004 Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice. Cell 119:121-135
21. Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O, Ahmad F, Matsui T, Chin S, Wu PH, Rybkin II, Shelton JM, Manieri M, Cinti S, Schoen FJ, Bassel-Duby R, Rosenzweig A, Ingwall JS, Spiegelman BM 2005 Transcriptional coactivator PGC-1α controls the energy state and contractile function of cardiac muscle. Cell Metab 1:259-271
22. Spiegelman BM, Heinrich R 2004 Biological control through regulated transcriptional coactivators. Cell 119:157-167
23. St. Pierre J, Lin J, Krauss S, Tarr PT, Yang R, Newgard CB, Spiegelman BM 2003 Bioenergetic analysis of peroxisome proliferator-activated receptor γ coactivators 1α and 1β (PGC-1α and PGC-1β) in muscle cells. J Biol Chem 278:26597-26603
24. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM 1999 Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115-124
25. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP 2000 Peroxisome proliferator-activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 106:847-856
26. Wilson-Fritch L, Burkart A, Bell G, Mendelson K, Leszyk J, Nicoloro S, Czech M, Corvera S 2003 Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol 23:1085-1094
27. Gilkerson RW, Selker JM, Capaldi RA 2003 The cristal membrane of mitochondria is the principal site of oxidative phosphorylation. FEBS Lett 546:355-358
28. Rehling P, Brandner K, Pfanner N 2004 Mitochondrial import and the twin-pore translocase. Nat Rev Mol Cell Biol 5:519-530
29. Bauer MF, Gempel K, Reichert AS, Rappold GA, Lichtner P, Gerbitz KD, Neupert W, Brunner M, Hofmann S 1999 Genetic and structural characterization of the human mitochondrial inner membrane translocase. J Mol Biol 289:69-82
30. Sylvester JE, Fischel-Ghodsian N, Mougey EB, O'Brien TW 2004 Mitochondrial ribosomal proteins: candidate genes for mitochondrial disease. Genet Med 6:73-80
31. Nijtmans LG, de Jong L, Artal SM, Coates PJ, Berden JA, Back JW, Muijsers AO, van der Spek H, Grivell LA 2000 Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J 19:2444-2451
32. Mishra S, Murphy LC, Nyomba BL, Murphy LJ 2005 Prohibitin: a potential target for new therapeutics. Trends Mol Med 11:192-197
33. Shulman AI, Mangelsdorf DJ 2005 Retinoid X receptor heterodimers in the metabolic syndrome. N Engl J Med 353:604-615
34. Takamura T, Nohara E, Nagai Y, Kobayashi K 2001 Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARγ mRNA expression in 3T3-L1 adipocytes. Eur J Pharmacol 422:23-29
35. Hammond LE, Neschen S, Romanelli AJ, Cline GW, Ilkayeva OR, Shulman GI, Muoio DM, Coleman RA 2005 Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs. J Biol Chem 280:25629-25636
36. Onay-Besikci A, Campbell FM, Hopkins TA, Dyck JR, Lopaschuk GD 2003 Relative importance of malonyl CoA and carnitine in maturation of fatty acid oxidation in newborn rabbit heart. Am J Physiol Heart Circ Physiol 284:H283-H289
37. McGarry JD, Brown NF 1997 The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244:1-14
38. Welch JS, Ricote M, Akiyama TE, Gonzalez FJ, Glass CK 2003 PPARγ and PPARΔ- negatively regulate specific subsets of lipopolysaccharide and IFN-γ target genes in macrophages. Proc Natl Acad Sci USA 100:6712-6717
39. Brandt JM, Djouadi F, Kelly DP 1998 Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor α. J Biol Chem 273:23786-23792
40. Yu GS, Lu YC, Gulick T 1998 Co-regulation of tissue-specific alternative human carnitine palmitoyltransferase Iβ gene promoters by fatty acid enzyme substrate. J Biol Chem 273:32901-32909
41. Djouadi F, Brandt JM, Weinheimer CJ, Leone TC, Gonzalez FJ, Kelly DP 1999 The role of the peroxisome proliferator-activated receptor α (PPARα) in the control of cardiac lipid metabolism. Prostaglandins Leukot Essent Fatty Acids 60:339-343
42. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W 1999 Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J Clin Invest 103:1489-1498
43. Lee CH, Olson P, Evans RM 2003 Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144:2201-2207
44. Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, Miroux B, Couplan E, Alves-Guerra MC, Goubern M, Surwit R, Bouillaud F, Richard D, Collins S, Ricquier D 2000 Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 26:435-439
45. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig AJ, Boss O, Kim YB, Zheng XX, Wheeler MB, Shulman GI, Chan CB, Lowell BB 2001 Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, β cell dysfunction, and type 2 diabetes. Cell 105:745-755
46. Brand MD, Esteves TC 2005 Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab 2:85-93
47. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM 1998 A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829-839
48. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM 2001 Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131-138
49. Russell LK, Mansfield CM, Lehman JJ, Kovacs A, Courtois M, Saffitz JE, Medeiros DM, Valencik ML, McDonald JA, Kelly DP 2004 Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor γ coactivator-1α promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ Res 94:525-533
50. Lowell BB, Shulman GI 2005 Mitochondrial dysfunction and type 2 diabetes. Science 307:384-387